Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STX vs GSK✓SelectedUSD · GSKSTX vs GSK performance historyLatest closeAs of+1.06%11/19
Stock and ETF performance explorer

STX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,852.3%
GSK return
+97.7%
Excess return
+1,754.6%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%-1.6%+2.6%+1.5%
7D-4.4%-4.7%+0.4%-3.2%
30D-22.8%-4.7%-18.1%-22.0%
3M-37.3%-8.8%-28.6%-36.1%
6M-28.8%-4.6%-24.2%-29.2%
YTD+89.9%+1.0%+89.0%+83.3%
1Y+102.4%+6.9%+95.5%+91.0%
3Y+629.4%+52.5%+576.9%+478.0%
5Y+496.2%+40.3%+455.9%+381.0%
All+1,852.3%+97.7%+1,754.6%+1,188.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling